Healthcare resource utilisation and related costs of patients with CKD from the UK: a report from the DISCOVER CKD retrospective cohort

Methods and rationale of the DISCOVER CKD global observational study

(2021) Roberto Pecoits-Filho et al.   Clinical Kidney Journal

POS-323 INSIDE CKD: PROJECTING THE FUTURE BURDEN OF CHRONIC KIDNEY DISEASE IN EUROPE USING MICROSIMULATION MODELLING

(2021) J.J. GARCIA SANCHEZ et al.   Kidney International Reports

Chronic kidney disease in adults: assessment and management

(2020) Anna Forbes et al.   CLINICAL MEDICINE

Dapagliflozin in Patients with Chronic Kidney Disease

(2020) Hiddo J.L. Heerspink et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

(2020) George L. Bakris et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis

(2019) Tadashi Toyama et al.   DIABETES OBESITY & METABOLISM

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

(2019) Vlado Perkovic et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diabetes and chronic kidney disease: an increasingly common multi-morbid disease in need of a paradigm shift in care

(2018) P. H. Winocour   DIABETIC MEDICINE

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

(2018) Stephen D. Wiviott et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England

(2018) Nga T. Q. Nguyen et al.   PLoS One

Reducing the costs of chronic kidney disease while delivering quality health care: a call to action

(2017) Raymond Vanholder et al.   Nature Reviews Nephrology

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

(2017) Bruce Neal et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Association Between Multimorbidity, Socioeconomic Factors, And Multimorbidity-Related Excess Healthcare Use - Results From The 2014 National Health Interview Survey

(2017) PA Laires et al.   VALUE IN HEALTH

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

(2016) Christoph Wanner et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease

(2016) Virginia Wang et al.   SEMINARS IN NEPHROLOGY

Data Resource Profile: Clinical Practice Research Datalink (CPRD)

(2015) Emily Herrett et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease

(2015) Merlin C. Thomas et al.   Nature Reviews Nephrology

What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?

(2015) Seamus Kent et al.   BMC Nephrology

Prevalence of Anemia in Chronic Kidney Disease in the United States

(2014) Melissa E. Stauffer et al.   PLoS One

Chronic Kidney Disease and the Aging Population

(2014) Karsten Midtvedt et al.   TRANSPLANTATION

Chronic kidney disease: global dimension and perspectives

(2013) Vivekanand Jha et al.   LANCET

Estimating the financial cost of chronic kidney disease to the NHS in England

(2012) Marion Kerr et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Prediction of ESRD and Death Among People With CKD: The Chronic Renal Impairment in Birmingham (CRIB) Prospective Cohort Study

(2010) Martin J. Landray et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report

(2010) Andrew S. Levey et al.   KIDNEY INTERNATIONAL

Chronic Kidney Disease and Its Complications

(2008) Robert Thomas et al.   PRIMARY CARE